ofloxacin has been researched along with Francisella tularensis Infection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, M; Knabbe, C; Seibold, E; Splettstoesser, W; Weile, J | 1 |
| Carness, P; Chopra, AK; Eaves-Pyles, T; Haithcoat, JL; Kirtley, M; Klimpel, GR; Moen, ST; Nasr, AB; Niesel, DW; Peterson, JW; Taormina, J | 1 |
| Eaves-Pyles, TD; Jezek, GE; Pyles, RB | 1 |
| Dean, RE; Lever, MS; Nelson, M; Pearce, PC; Simpson, AJ; Stevens, DJ | 1 |
| Bens, G; Berton, M; Estève, E; Nojavan, H | 1 |
| Hooper, CJ; Limaye, AP | 1 |
| Aranda, EA | 1 |
| Räisäinen, S; Schildt, R; Syrjälä, H | 1 |
1 review(s) available for ofloxacin and Francisella tularensis Infection
| Article | Year |
|---|---|
Treatment of tularemia with fluoroquinolones: two cases and review.
Topics: Adult; Anti-Infective Agents; Bacteremia; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tularemia | 1999 |
7 other study(ies) available for ofloxacin and Francisella tularensis Infection
| Article | Year |
|---|---|
Treatment of tularemia in patient with chronic graft-versus-host disease.
Topics: Anti-Bacterial Agents; Chronic Disease; Doxycycline; Francisella tularensis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Tularemia | 2013 |
Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.
Topics: Administration, Intranasal; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Formation; Colony Count, Microbial; Enzyme-Linked Immunosorbent Assay; Female; Francisella tularensis; Levofloxacin; Mice; Mice, Inbred BALB C; Ofloxacin; Survival Analysis; Tularemia; Virulence; Zoonoses | 2008 |
Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cells, Cultured; Colony Count, Microbial; Cytokines; Female; Francisella tularensis; Humans; Immunologic Factors; Levofloxacin; Lung; Mice; Mice, Inbred BALB C; Monocytes; Neutrophils; Ofloxacin; Poly I-C; Respiratory Tract Infections; Survival Analysis; Toll-Like Receptor 3; Tularemia | 2010 |
Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus).
Topics: Animals; Anti-Bacterial Agents; Callithrix; Chromatography, Liquid; Drug Administration Schedule; Female; Francisella tularensis; Levofloxacin; Male; Ofloxacin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Treatment Outcome; Tularemia | 2010 |
[Localized inflammatory alopecia of the scalp: an unusual presentation of tularemia].
Topics: Alopecia; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Lymphatic Diseases; Middle Aged; Ofloxacin; Scalp; Skin Diseases, Papulosquamous; Tularemia | 2012 |
Treatment of tularemia with levofloxacin.
Topics: Aged; Anti-Infective Agents; Francisella tularensis; Humans; Levofloxacin; Male; Ofloxacin; Tularemia | 2001 |
In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Tularemia | 1991 |